PharmGKB Blog
Monday, July 16, 2012

New PGRN Featured Project and PI for the Month of July

›
The PGRN website is featuring a new project and investigator of the month from the PHAT (Pharmacogenetics of Asthma Treatment) group. ...
Thursday, July 12, 2012

Effect of a genetic variant associated with Multiple Sclerosis mirrors response to anti-TNF therapy

›
Though anti-TNF therapy can be effective in the treatment of many auto-immune diseases including Rheumatoid Arthritis (RA), drugs that block...
Tuesday, July 10, 2012

New pathways on PharmGKB: Sorafenib PK and PD

›
We have added two new pathways: Sorafenib PK and PD pathways to our pathway collections.  Sorafenib (Nexavar, BAY 43-9006) is a cancer ...
Monday, July 9, 2012

New Relationships File Available

›
PharmGKB has a new relationships file available for download. This file catalogs all the current relationships between drugs, genes, disease...
Tuesday, July 3, 2012

PharmGKB has an opening for a scientific curator

›
PharmGKB is looking to fill a Curator position in the Department of Genetics at Stanford University.  We are specifically looking for someon...
Friday, June 29, 2012

Genetic contribution of response to opioids

›
Opioids  are commonly prescribed for pain relief, yet many individuals suffer adverse side effects such as nausea, dizziness and sedation. ...
Tuesday, June 26, 2012

Helix Group & PharmGKB Retreat

›
Much fun and team-building was had at the Stanford Helix Group & PharmGKB retreat in San Diego last week - including sea kayaking, ins...
‹
›
Home
View web version

Contributors

  • Caroline Thorn, Curator
  • Katrin Sangkuhl
  • Li Gong
  • Mark Woon
  • Mark Woon
  • Michelle Whirl-Carrillo, Director and Co-PI
  • Ryan Whaley, Technical Lead
  • Teri Klein, Co-PI PharmGKB, CPIC, PharmCAT & ClinGen
Powered by Blogger.